Ozempic-like drugs have more benefits to the body than just losing weight, meta-analysis shows

A meta-analysis of 10 randomized controlled trials involving much than 23,000 participants, presented astatine the International Congress connected Obesity (ICO 2026), hosted by the World Obesity Federation (WOF) successful Mexico City, Mexico (July 15–17), shows that the GLP-1 people of obesity drugs is associated with a marked simplification successful systemic inflammation beyond its anti-obesity effects, perchance explaining however the drugs tin trim cardiovascular hazard factors.